Franklin Resources Inc Iterum Therapeutics PLC Transaction History

Franklin Resources Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.19 - $0.36 $23,830 - $45,151	-125,422 Reduced 32.64%	258,778 $52,000
Q3 2021 Nov 12, 2021	BUY	$0.54 - $2.29 $207,468 - $879,818	384,200 New	384,200 $215,000
Q4 2019 Feb 12, 2020	SELL	$1.7 - $5.99 $417,843 - $1.47 Million	-245,790 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$5.77 - $7.65 $610,287 - $809,132	-105,769 Reduced 30.09%	245,790 $1.45 Million
Q2 2019 Aug 14, 2019	SELL	$6.09 - $9.1 $36,272 - $54,199	-5,956 Reduced 1.67%	351,559 $2.42 Million
Q3 2018 Nov 13, 2018	SELL	$6.24 - $10.4 $169,104 - $281,840	-27,100 Reduced 7.05%	357,515 $2.4 Million
Q2 2018 Aug 14, 2018	BUY	$10.67 - $12.85 $4.1 Million - $4.94 Million	384,615 New	384,615 $4.19 Million

145

Ticker ITRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,233,400
Market Cap $30.1M
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.